Molecular profiling of blastic plasmacytoid dendritic cell neoplasm reveals a unique pattern and suggests selective sensitivity to NF-kB pathway inhibition

Livio Pagano, M. R. Sapienza, F. Fuligni, C. Agostinelli, C. Tripodo, S. Righi, M. A. Laginestra, A. Pileri Jr., M. Mancini, M. Rossi, F. Ricci, A. Gazzola, F. Melle, C. Mannu, F. Ulbar, M. Arpinati, M. Paulli, T. Maeda, D. Gibellini, N. PimpinelliM. Santucci, L. Cerroni, C. M. Croce, F. Facchetti, P. P. Piccaluga, S. A. Pileri

Risultato della ricerca: Contributo in rivistaArticolo in rivista

87 Citazioni (Scopus)

Abstract

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare disease of controversial origin recently recognized as a neoplasm deriving from plasmacytoid dendritic cells (pDCs). Nevertheless, it remains an orphan tumor with obscure biology and dismal prognosis. To better understand the pathobiology of BPDCN and discover new targets for effective therapies, the gene expression profile (GEP) of 25 BPDCN samples was analyzed and compared with that of pDCs, their postulated normal counterpart. Validation was performed by immunohistochemistry (IHC), whereas functional experiments were carried out ex vivo. For the first time at the molecular level, we definitely recognized the cellular derivation of BPDCN that proved to originate from the myeloid lineage and in particular, from resting pDCs. Furthermore, thanks to an integrated bioinformatic approach we discovered aberrant activation of the NF-kB pathway and suggested it as a novel therapeutic target. We tested the efficacy of anti-NF-kB-treatment on the BPDCN cell line CAL-1, and successfully demonstrated by GEP and IHC the molecular shutoff of the NF-kB pathway. In conclusion, we identified a molecular signature representative of the transcriptional abnormalities of BPDCN and developed a cellular model proposing a novel therapeutic approach in the setting of this otherwise incurable disease.
Lingua originaleEnglish
pagine (da-a)1606-1616
Numero di pagine11
RivistaLeukemia
Volume28
DOI
Stato di pubblicazionePubblicato - 2014

Keywords

  • leukemia

Fingerprint

Entra nei temi di ricerca di 'Molecular profiling of blastic plasmacytoid dendritic cell neoplasm reveals a unique pattern and suggests selective sensitivity to NF-kB pathway inhibition'. Insieme formano una fingerprint unica.

Cita questo